Crinetics Pharmaceuticals... (CRNX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
38.14
-0.07 (-0.18%)
At close: Jan 28, 2025, 2:59 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 54.90M | 32.67M | 200.69M | 93.09M | 40.33M | 44.97M | 14.19M | 12.15M |
Short-Term Investments | 503.66M | 301.75M | 133.01M | 77.79M | 78.07M | 118.90M | n/a | n/a |
Long-Term Investments | 1.77M | 1.97M | 1.01M | 500.00K | 500.00K | 500.00K | n/a | n/a |
Other Long-Term Assets | 2.00M | 37.00K | 568.00K | 40.00K | 82.00K | n/a | 33.00K | 10.00K |
Receivables | 9.35M | n/a | 2.03M | 1.83M | n/a | n/a | 734.00K | 72.00K |
Inventory | n/a | n/a | 8.07M | -1.83M | -1.38M | n/a | 141.00K | 98.00K |
Other Current Assets | 6.25M | 10.76M | 8.07M | 4.78M | 1.32M | 876.00K | 239.00K | 43.00K |
Total Current Assets | 574.15M | 345.18M | 344.72M | 177.49M | 123.34M | 166.68M | 15.16M | 12.37M |
Property-Plant & Equipment | 57.43M | 4.99M | 4.72M | 5.41M | 6.46M | 4.23M | 400.00K | 224.00K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 61.20M | 6.99M | 6.29M | 5.95M | 7.04M | 4.73M | 433.00K | 234.00K |
Total Assets | 635.35M | 352.18M | 351.01M | 183.44M | 130.38M | 171.41M | 15.60M | 12.60M |
Account Payables | 6.55M | 6.88M | 3.42M | 3.49M | 2.70M | 1.46M | 403.00K | 340.00K |
Deferred Revenue | 2.06M | 2.24M | -939.00K | -835.00K | -724.00K | n/a | n/a | n/a |
Short-Term Debt | 4.17M | 1.05M | n/a | n/a | n/a | n/a | n/a | 49.00K |
Other Current Liabilities | 31.16M | 17.55M | 12.57M | 7.00M | 5.64M | 6.47M | 494.00K | 501.00K |
Total Current Liabilities | 43.94M | 27.72M | 15.99M | 10.49M | 8.34M | 7.92M | 897.00K | 890.00K |
Long-Term Debt | 47.55M | 2.02M | 3.07M | 4.01M | 4.85M | n/a | n/a | 163.00K |
Other Long-Term Liabilities | n/a | n/a | 2.00K | 23.00K | 49.00K | 3.27M | 29.72M | 17.75M |
Total Long-Term Liabilities | 52.30M | 8.13M | 3.08M | 4.04M | 4.90M | 3.27M | 29.72M | 17.91M |
Total Liabilities | 96.25M | 35.85M | 19.07M | 14.53M | 13.24M | 11.19M | 30.62M | 18.80M |
Total Debt | 51.73M | 2.02M | 3.07M | 4.01M | 4.85M | n/a | n/a | 212.00K |
Common Stock | 1.19B | 759.43M | 607.58M | 336.51M | 210.79M | 24.00K | 1K | 1K |
Retained Earnings | -653.70M | -439.17M | -275.25M | -167.61M | -93.80M | -43.38M | -16.27M | -7.11M |
Comprehensive Income | 977.00K | -3.93M | -382.00K | 25.00K | 148.00K | 61.00K | -304.00K | -182.00K |
Shareholders Equity | 539.11M | -439.17M | -275.25M | -167.61M | -93.80M | -43.38M | -15.02M | -6.20M |
Total Investments | 505.43M | 301.75M | 134.02M | 77.79M | 78.07M | 118.90M | n/a | n/a |